GENEREX BIOTECHNOLOGY CORP: 10-Q filed 2017-06-15
What GENEREX BIOTECHNOLOGY CORP reported in its quarterly report filed 2017-06-15 (fiscal Q3 2017): 28 published measures, 68 facts as tagged in accession 0001607062-17-000228.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-06-15
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001607062-17-000228 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENEREX BIOTECHNOLOGY CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 13,192,754 | USD | |
| At 2016-07-31 | 26,274 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 80,652,856 | USD | |
| At 2016-07-31 | 11,243,124 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 37,068 | USD | |
| At 2016-07-31 | 16,899 | USD | |
| At 2016-04-30 | 47,171 | USD | |
| At 2015-07-31 | 749,965 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | -49,223,316 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -64,446,265 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 918,361 | USD | 90 |
| 2015-08-01 to 2016-04-30 | -860,293 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | -528,195 | USD | 273 |
| 2015-08-01 to 2016-04-30 | -698,029 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | 4,521,905 | USD | 273 |
| 2015-08-01 to 2016-04-30 | 2,952 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | -3,987,637 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 437,000,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 1,056,343 | shares | 89 |
| 2016-08-01 to 2017-04-30 | 960,054 | shares | 273 |
| 2016-02-01 to 2016-04-30 | 900,057 | shares | 90 |
| 2015-08-01 to 2016-04-30 | 873,309 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 1,056,343 | shares | 89 |
| 2016-08-01 to 2017-04-30 | 960,054 | shares | 273 |
| 2016-02-01 to 2016-04-30 | 900,133 | shares | 90 |
| 2015-08-01 to 2016-04-30 | 873,309 | shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 1,922 | USD | |
| At 2016-07-31 | 1,298 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-08-01 to 2016-07-31 | 30,297 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | -534,008 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -852,553 | USD | 273 |
| 2016-02-01 to 2016-04-30 | -144,298 | USD | 90 |
| 2015-08-01 to 2016-04-30 | -1,619,408 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 4,070,908 | USD | |
| At 2016-07-31 | 24,976 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 186,463 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 429,971 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 106,855 | USD | 90 |
| 2015-08-01 to 2016-04-30 | 306,768 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 23,985,349 | USD | |
| At 2016-07-31 | 9,000,870 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-01-18 | 14,300,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 534,008 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 852,553 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 144,298 | USD | 90 |
| 2015-08-01 to 2016-04-30 | 1,619,408 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 22,705 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 187,786 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 263,426 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 71,028 | USD | 90 |
| 2015-08-01 to 2016-04-30 | 316,226 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 1,068,101 | shares | |
| At 2016-07-31 | 908,541 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 812,945 | USD | |
| At 2016-07-31 | 798,872 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-04-30 | 1,955,932 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | -42,091,301 | USD | 89 |
| 2016-08-01 to 2017-04-30 | -57,286,967 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 918,361 | USD | 90 |
| 2015-08-01 to 2016-04-30 | -860,293 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-02-01 to 2017-04-30 | 346,222 | USD | 89 |
| 2016-08-01 to 2017-04-30 | 589,127 | USD | 273 |
| 2016-02-01 to 2016-04-30 | 73,270 | USD | 90 |
| 2015-08-01 to 2016-04-30 | 1,303,182 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | 2,327 | USD | 273 |
| 2015-08-01 to 2016-04-30 | 194,215 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | 980 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-08-01 to 2017-04-30 | -1,564 | USD | 273 |
Inspect the source
- Entity
- GENEREX BIOTECHNOLOGY CORP / CIK 0001059784
- Captured
- SEC response SHA-256
a8779b8c3aa8286320834b30d50af09999238cecacb9e7883d21e11477763a4d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001059784.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))